(Medical Xpress) -- An Auburn University team of chemical and biomedical engineers led by Mark Byrne, the Daniel F. and Josephine Breeden Associate Professor in the Samuel Ginn College of Engineering, has developed a new ...
Nov 9, 2011
0
0
Many adults take prescription drugs, and usage rates are continually increasing. With approximately 1.3 million emergency department visits in the U.S. caused by adverse drug events each year, patient education is becoming ...
Apr 24, 2023
0
3
With COVID-19 on our minds, it may be easy to forget about another potential danger: the sun.
Aug 18, 2020
0
2
Do medicines arrive in the right amount at the right spot in our brain? By making a model that depicts our brain in small "brain blocks," Ph.D. student Esmée Vendel tries to find an answer to this question. She made a mathematical ...
Dec 16, 2019
0
3
The timing of food intake in the early phase of TB treatment could have a negative impact on the effectiveness of TB treatment.
Sep 7, 2014
0
0
BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called AccurinsTM, announced today the presentation of late-breaker clinical data for BIND-014, ...
Apr 4, 2012
0
0
